AirInSpace Plasmer Technology Certified To Protect Aircraft Passengers And Crew From Biological Threats

Washington, DC - AirInSpace announced recently that its partner, Montreal-based Air Data Inc. (ADI), has been certified by the airworthiness branch of Transport Canada to manufacture and market ADI's JetAir Bio-Protection System (BPS), business jet version. The BPS is based on AirInSpace's patented Plasmer technology, which also is being used in the International Space Station (ISS), and in hospitals under the brand name HEPA-MD.

Certification of the BPS establishes the airworthiness of the product so that ADI's customers may proceed with aircraft BPS installations, initially on Bombardier Global Series aircraft. ADI previously announced the definitive results of avian flu testing on its Bio-Protection System. Conducted at the Laboratoire de Virologie et Pathogénèse Virale in Lyon, France, the tests showed a complete reduction of avian flu viruses by the BPS—i.e., from a high concentration of virus at its inlet to an undetectable level exiting the unit.

"At a time of increasing worries within the aviation industry regarding on-aircraft exposure to emerging risks like the avian flu, we are very pleased to be able to confirm the availability of a solution that will enhance the health and security of the traveling public to new levels," said Jean-Pierre Lepage, President of Air Data. "One of the main breakthroughs associated with AirInSpace's cold plasma technology is its ability not only to remove biological contaminants from cabin air but also to destroy them completely. In the case of avian flu, this is particularly important, given the ability of this specific organism to remain potent for several days in the external environment."

"Air Data's JetAir BPS provides a quantum leap in airplane air purity, protecting both passengers and crew from a wide range of air contaminants, especially biological threats such as SARS and avian flu," said Laurent Fullana, CEO of AirInSpace. "We are extremely pleased that the BPS solution uses our patented cold plasma ionic interaction technology as pioneered in space and used today to protect astronauts on the International Space Station as well as patients and staff in over 100 international hospitals. The inactivation and germicidal effects of our plasma technology have been demonstrated even against one of the most resistant microorganisms: Bacillus atrophaeus spores, an anthrax surrogate."

SOURCE: AirInSpace